Patents by Inventor Zhangjie Wang

Zhangjie Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240066048
    Abstract: Heparin compounds and synthetic heparin analogues having short acting anticoagulant activity are provided. Methods of synthesizing such heparin compounds, including chemoenzymatic pathways using sulfotransferase enzymes are provided. Methods of treating subjects in need of anticoagulant activity are provided.
    Type: Application
    Filed: July 17, 2023
    Publication date: February 29, 2024
    Applicant: The University of North Carolina at Chapel Hill
    Inventors: Jian Liu, Zhangjie Wang, Po-Hung Hsieh, Yongmei Xu
  • Patent number: 11903963
    Abstract: Heparin compounds and synthetic heparin analogues having short acting anticoagulant activity are provided. Methods of synthesizing such heparin compounds, including chemoenzymatic pathways using sulfotransferase enzymes are provided. Methods of treating subjects in need of anticoagulant activity are provided.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: February 20, 2024
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Jian Liu, Zhangjie Wang, Po-Hung Hsieh, Yongmei Xu
  • Patent number: 11701380
    Abstract: Heparin compounds and synthetic heparin analogues having short acting anticoagulant activity are provided. Methods of synthesizing such heparin compounds, including chemoenzymatic pathways using sulfotransferase enzymes are provided. Methods of treating subjects in need of anticoagulant activity are provided.
    Type: Grant
    Filed: March 12, 2018
    Date of Patent: July 18, 2023
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Jian Liu, Zhangjie Wang, Po-Hung Hsieh, Yongmei Xu
  • Publication number: 20210137967
    Abstract: Heparin compounds and synthetic heparin analogues having short acting anticoagulant activity are provided. Methods of synthesizing such heparin compounds, including chemoenzymatic pathways using sulfotransferase enzymes are provided. Methods of treating subjects in need of anticoagulant activity are provided.
    Type: Application
    Filed: March 12, 2018
    Publication date: May 13, 2021
    Inventors: Jian Liu, Zhangjie Wang, Po-Hung Hsieh, Yongmei Xu